Lisata Therapeutics Inc
NASDAQ:LSTA
Lisata Therapeutics Inc
NASDAQ:LSTA
Price:
5.01
USD
-0.2%
Market Cap:
$44.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lisata Therapeutics Inc
NASDAQ:LSTA
|
US |
|
K
|
Koses Co Ltd
KOSDAQ:089890
|
KR |
|
Ensign Energy Services Inc
TSX:ESI
|
CA |
|
Grupo Aeroportuario del Sureste SAB de CV
BMV:ASURB
|
MX |
|
UMH Properties Inc
NYSE:UMH
|
US |
|
B
|
Banco Santander-Chile
SGO:BSANTANDER
|
CL |
Relative Value
The Relative Value of one
LSTA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.01 USD,
Lisata Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LSTA Relative Value
HIDDEN
Multiples Across Competitors
LSTA Competitors Multiples
Lisata Therapeutics Inc Competitors
Lisata Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lisata Therapeutics Inc
NASDAQ:LSTA
|
43.9m USD | 41 | -2.4 | -1.2 | -1.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86 | 14.3 | 19.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.1 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 10.9 | 128.9 | 72.1 | 80.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
